Natalizumab for Moderate-to-Severe Crohn's Disease.

Article Details

Citation
Copy to clipboard

Dryden GW

Natalizumab for Moderate-to-Severe Crohn's Disease.

Gastroenterol Hepatol (N Y). 2008 Apr;4(4):296.

PubMed ID
21960916 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs